Design and synthesis of novel antimicrobial peptide scaffolds

Andreja Jakas1, Kristina Vlahoviček-Kahlina1, Vanja Ljolić-Bilić2

  • 1Division of Organic Chemisty and Biochemistry, Rudjer Bošković Institute, Zagreb 10000-HR, Croatia.

Bioorganic Chemistry
|September 6, 2020
PubMed

Insights

Researchers synthesized novel glycopeptides incorporating muramic acid (Mur), a bacterial cell wall component. One linear glycopeptide demonstrated antimicrobial activity against Staphylococcus aureus, highlighting potential for new antibacterial agents.

Area of Science:

  • Biochemistry
  • Organic Chemistry
  • Microbiology

Background:

  • Muramic acid (Mur) is a key component of bacterial peptidoglycan.
  • Incorporating Mur into peptide scaffolds for antimicrobial studies presents synthetic challenges.
  • Peptidoglycan is essential for bacterial cell wall integrity.

Purpose of the Study:

  • To synthesize glycopeptide libraries containing muramic acid.
  • To investigate the antimicrobial activity of these novel glycopeptides.
  • To explore the potential of Mur-containing peptides as antibacterial agents.

Main Methods:

  • Solid-phase peptide synthesis (SPPS) was employed to create linear and cyclic glycopeptide libraries.
  • Four building units were utilized: Mur, Leu-Ser-Lys-Leu (LSKL), Nε-Lys, and Asn.
  • Antimicrobial activity was assessed against standard laboratory microbial strains.

Main Results:

  • A linear glycopeptide (Leu-Ser-Lys-Leu-Nε-Lys-Mur-Asn) showed activity against Staphylococcus aureus (Gram-positive bacteria).
  • The synthesized glycopeptides did not exhibit activity against tested human tumor and normal cell lines.
  • Control LSKL peptide sequence was also tested for comparison.

Conclusions:

  • Novel glycopeptides incorporating muramic acid were successfully synthesized.
  • The study identified a specific linear glycopeptide with selective antibacterial activity against Gram-positive bacteria.
  • The findings suggest potential for developing Mur-based glycopeptides as targeted antibacterial therapeutics.